亦诺微,ImmVira,周国瑛
Founded date: 2015
Investors 1
| Date | Name | Website |
| - | triwise | en.triwise... |
Mentions in press and media 1
| Date | Title | Description |
| 10.06.2025 | ImmVira Announces First Patient Dosed in a Multi-Regional Phase II Clinical Trial Evaluating MVR-T3011 Oncolytic Immunotherapy in Patients with BCG-Unresponsive High-Risk Non-Muscle-Invasive Bladder C... | SUZHOU, China, June 10, 2025 /PRNewswire/ -- ImmVira, a global leading clinical-stage biotechnology company focused on the development of next-generation novel oncolytic immunotherapy for treatment of cancer, announced that the first patien... |